Enanta Pharmaceuticals Inc (NASDAQ: ENTA) stock closed at $5.59 on 2/11/25 after a major increase of 14.1%. Moreover, this advance was accompanied by exceptionally high trading volume at 200% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 8.1% during the last week.
Current PriceTarget Research Rating
Enanta Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. Enanta Pharmaceuticals has a slightly negative Appreciation Score of 36 and a very low Power Rating of 14, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment